Source: Pharmabiz

Cancer Research UK: Cancer Research UK & KisoJi Biotechnology collaborate to advance the first naked antibody against TROP2 into clinical trial

Cancer Research UK, one of the world's largest funders of cancer research, and KisoJi Biotechnology Inc., a company focussed on the discovery and development of antibody therapeutics, have signed a

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
1.0-5.0K
Michelle Mitchell's photo - CEO of Cancer Research UK

CEO

Michelle Mitchell

CEO Approval Rating

94/100

Read more